Banco Santander S.A. Has $1.43 Million Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Banco Santander S.A. decreased its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.6% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,485 shares of the exchange traded fund’s stock after selling 534 shares during the period. Banco Santander S.A.’s holdings in SPDR S&P Biotech ETF were worth $1,431,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in XBI. Hartline Investment Corp boosted its holdings in shares of SPDR S&P Biotech ETF by 2.0% during the 3rd quarter. Hartline Investment Corp now owns 5,502 shares of the exchange traded fund’s stock worth $544,000 after buying an additional 106 shares in the last quarter. Intellectus Partners LLC lifted its position in shares of SPDR S&P Biotech ETF by 1.0% during the 2nd quarter. Intellectus Partners LLC now owns 11,334 shares of the exchange traded fund’s stock valued at $1,051,000 after acquiring an additional 113 shares during the period. Pacific Center for Financial Services boosted its stake in SPDR S&P Biotech ETF by 2.8% during the first quarter. Pacific Center for Financial Services now owns 4,359 shares of the exchange traded fund’s stock worth $414,000 after acquiring an additional 118 shares in the last quarter. Signature Estate & Investment Advisors LLC grew its holdings in SPDR S&P Biotech ETF by 5.7% in the third quarter. Signature Estate & Investment Advisors LLC now owns 2,336 shares of the exchange traded fund’s stock worth $231,000 after purchasing an additional 125 shares during the period. Finally, Denver Wealth Management Inc. increased its stake in SPDR S&P Biotech ETF by 0.9% in the third quarter. Denver Wealth Management Inc. now owns 14,779 shares of the exchange traded fund’s stock valued at $1,460,000 after purchasing an additional 127 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

XBI stock opened at $96.24 on Friday. The company’s 50-day moving average is $98.44 and its 200-day moving average is $96.23. The stock has a market capitalization of $7.34 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 1 year low of $71.99 and a 1 year high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.